title: Questions regarding the design of the study of pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al.
authors.forename: J H
authors.initials: JH
authors.lastname: Stone
authors.forename: D B
authors.initials: DB
authors.lastname: Hellmann
mesh_terms: D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D003520:Cyclophosphamide